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EDITORIAL
Looking forward to 
Harrogate, 2012
November may sound a long way off to most people but time will soon pass and the annual Wounds UK Harrogate 
event will be upon us (12–14, November). 
We are busy planning the programme, 
which this year will focus on ‘Sharing best 
practice’ across the four nations of the UK. 
The call for papers has now gone out (www.
wounds-uk.com) and we encourage you to 
submit a paper for consideration, either  as 
a free paper or poster. We want you to share 
your best practice, experiences of using new 
products, innovations, research, case studies, 
patient experiences, or anything else that you 
think colleagues will be interested in. 
It is important that as clinicians, we share 
our experiences so that we can discuss 
what we have learnt, how the change has 
affected clinical practice, and how quality 
of life for patients has been improved. 
Regional groups across the UK are all 
developing guidance and best practice 
statements and are actively involved in 
audit/research/evaluation — Harrogate 
offers the opportunity to share these 
developments with others. 
Through sharing best practice we can 
continue to develop tissue viability as a 
forward-thinking specialty, which embraces 
change and incorporates evidence to 
promote the wellbeing of patients. As usual, 
the Harrogate conference will be supported 
by our industry partners who provide the 
opportunity for us to see new products, 
discuss established technology, and learn 
about the research that supports their work. 
Importantly, visiting the exhibition allows 
us to discuss the realities of clinical practice 
and how industry can support us with 
products that meet the ever-changing needs 
of the patient with skin integrity issues. 
The importance of working with business 
has government backing in Innovation, 
Health and Wealth (Department of 
Health [DoH], 2011), a publication that 
recognises the importance of working 
closely with industry to promote, develop 
and implement a quality healthcare 
service to all users. It identifies that the 
challenge for the NHS and industry is 
to pursue innovations that genuinely 
add value — but not cost — to health 
care. The authors go on to explain that 
innovation is a process of development, 
implementation and the dissemination of 
ideas into widespread use through three 
key stages:
 Invention: originating ideas for new 
services or products, or new ways of 
providing a service
 Adoption: putting any new idea, 
product or service into practice, 
including prototyping, piloting, 
testing and evaluating its safety and 
effectiveness
 Diffusion: the systematic uptake 
of the idea, service or product into 
widespread use across the whole 
service (DoH, 2011). 
The NHS and industry can complement 
each other — the NHS through its 
productivity and quality, and industry 
through its competitiveness. A successful 
collaboration will add value to services 
and reduce costs. 
Harrogate provides the ideal arena 
for clinicians, academics, scientists, 
researchers, and industry colleagues to 
learn about developments across the UK 
as well as networking in an environment 
that provides the latest tissue viability 
education and research.
Finally, despite all the current changes, it is 
worth repeating that the purpose of the NHS, 
and everyone working within it, is to provide 
high quality health care, free at the point of 
delivery to everyone who needs it. Wuk
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